Canonical inflammasomes activate caspase-1 through diverse biochemical mechanisms, serving as cytosolic immunity against infection or danger signals ([@bib29]). Activated caspase-1 processes IL-1β/18 for its maturation and secretion and also triggers pyroptotic cell death through cleavage of the gasdermin D protein ([@bib9]; [@bib19]). Assembly of the inflammasome is mediated by a stimulus-responsive pattern recognition receptor (PRR) that specifies the nature and function of the inflammasome. The PRR then recruits an inflammasome adaptor ASC (apoptosis-associated speck-like protein containing a CARD) or NLRC4, forming a large platform for caspase-1 activation ([@bib7]). PRRs functioning as inflammasome sensors include NLRP3, AIM2, NAIPs, NLRP1, and Pyrin, all of which can detect or exclusively recognize bacterial signals ([@bib6]; [@bib29]).

The NAIP/NLRC4 inflammasome is best characterized with a 3D structure determined ([@bib8]; [@bib27]; [@bib28]). NAIPs are the only NLRs proved to be inflammasome receptors ([@bib10]; [@bib30]; [@bib26]; [@bib21]). One activated NAIP molecule recruits and activates one NLRC4 molecule that then propagates its active conformation to 8--10 more NLRC4 molecules to form a wheel-shaped complex ([@bib8]; [@bib27]). The NAIP inflammasome is critical for antibacterial immunity ([@bib28]). Human NAIP recognizes the needle component of the bacterial type III secretion system (T3SS; [@bib30]). The T3SS is evolutionarily related to the flagellar export system. Mice have seven *Naips* located in the same genomic locus, among which *Naip1*, *2*, *5*, and *6* are expressed in C57BL/6 mice. NAIP1 is the orthologue of human NAIP, and NAIP2 recognizes the rod component of the T3SS; NAIP5 and 6 are cytosolic receptors for bacterial flagellin. The NAIP/NLRC4 inflammasome responds to a broad spectrum of pathogens, including *Salmonella*, *Shigella*, *Legionella*, and *Pseudomonas spp.*, in which NAIPs exhibit high ligand specificity ([@bib10]; [@bib30]; [@bib16]; [@bib26]; [@bib21]). Studies using *Nlrc4^−/−^* mice indicate a critical role of the NAIP/NLRC4 inflammasome in protecting mice from lethal infection with environmental bacteria such as *Chromobacterium violaceum* and *Burkholderia thailandensis* or an engineered *Salmonella* Typhimurium ectopically expressing flagellin or its T3SS rod protein ([@bib14]; [@bib1]; [@bib12]). In this process, neutrophil-mediated killing coordinated with IL-18--driven natural killer cell responses is proposed as the effector mechanism. Other studies suggest an epithelium-intrinsic function of the NAIP/NLRC4 inflammasome that expels infected enterocytes, thereby inhibiting bacterial replication in the intestine and colitis progression ([@bib15]; [@bib17]). NLRC4-driven IL-1β production from intestinal phagocytes can also discriminate between pathogenic and commensal bacteria in the gut ([@bib5]).

Hyperactivation of the NLRC4--caspase-1 axis is lethal to mice, and the lethality is caused by severe systemic inflammation, similar to excessive activation of the caspase-11--gasdermin D pathway in endotoxic shock ([@bib18], [@bib19]; [@bib9]). One study has shown that extraintestinal outgrowth of a multidrug-resistant *Escherichia coli* strain in antibiotics plus dextran sulfate sodium--treated mice causes sepsis-like lethality in an NAIP5/NLRC4-dependent manner ([@bib2]). Lethal NLRC4 inflammasome activation is best modeled by peritoneal injection of LFn-flagellin that efficiently delivers the flagellin protein into the cytosol ([@bib30]; [@bib26]). This defined assay has recorded a critical role of *Naip5*, *Nlrc4*, and *caspase-1* in the lethal response ([@bib22]).

Although the function of *Nlrc4* is extensively studied, the in vivo role of *Naips* in antibacterial defense and inflammatory damage are not fully defined yet. In this study, using macrophages derived from *Naip1^−/−^*, *Naip2^−/−^*, and *Naip5^−/−^* mice, we confirmed that NAIP1, 2, and 5 specifically recognize bacterial T3SS needle protein, rod protein, and flagellin, respectively, and examined the differential contribution of each NAIP in sensing various bacterial infections. The *Naips* are also required for lethal inflammasome activation in a ligand-specific manner. Finally, using the *S.* Typhimurium infection model ([@bib14]), we show that NAIP2/5 but not NAIP1 activation can clear the infection and promote the survival of infected mice.

RESULTS AND DISCUSSION {#s01}
======================

Generation of *Naip1^−/−^*, *Naip2^−/−^*, and *Naip5^−/−^* mice {#s02}
---------------------------------------------------------------

To assess the genetic function of different NAIP family members, we generated *Naip1^−/−^*, *Naip2^−/−^*, and *Naip5^−/−^* mice. Given the high polymorphism of the *Naip* locus in different mouse inbred strains ([@bib24]), the same genetic background (C57BL/6) was used to make the mice. The *Naip5^−/−^* allele was obtained in C57BL/6-derived embryonic stem (ES) cells through homologous recombination ([Fig. S1 A](http://www.jem.org/cgi/content/full/jem.20160006/DC1){#supp1}; see Materials and methods). The largest exon 9--encoding residues, Asp388 to Glu1092 (covering the entire nucleotide-binding oligomerization domain and two leucine-rich repeat units), were replaced with a neomycin-resistant cassette. The targeting was validated by PCR and subsequent DNA sequencing (Fig. S1 B). *Naip1^−/−^* and *Naip2^−/−^* mice were generated using transcription activator--like effector nuclease (TALEN)--based genome editing similarly as described previously ([@bib25]); the targeting sequences and validation of the KO alleles are detailed in Materials and methods. One homozygous *Naip1* mutant allele (Fig. S1 C) and two homozygous *Naip2* alleles (Fig. S1 D), all expected to produce a nonfunctional protein, were subjected to further functional analyses.

Macrophages from *Naip^−/−^* mice resist stimulation by the corresponding bacterial ligand {#s03}
------------------------------------------------------------------------------------------

Primary BMDMs were derived from the *Naip1^−/−^*, *Naip2^−/−^*, and *Naip5^−/−^* mice as well as the WT and *Nlrc4^−/−^* C57BL/6 mice as the positive and negative control, respectively. The cells were stimulated with different NAIP ligands or LPS plus nigericin and subjected to inflammasome activation assays. LPS plus nigericin, an activator of the NLRP3 inflammasome, triggered similar extents of caspase-1 activation in WT and all four KO BMDMs ([Fig. 1, A and B](#fig1){ref-type="fig"}), confirming the intact inflammasome responses in these genetically modified cells. Flagellin (*Pseudomonas aeruginosa*), the T3SS rod protein (Bsak from *B. thailandensis*), and needle protein (EprI from enterohemorrhagic *E. coli* \[EHEC\]) were delivered into the BMDMs using the LFn fusion strategy. As expected from previous studies ([@bib4]; [@bib13]; [@bib11]; [@bib10]; [@bib30]; [@bib26]), all three bacterial ligands did not activate caspase-1 in *Nlrc4^−/−^* BMDMs ([Fig. 1 B](#fig1){ref-type="fig"}), and *Naip5^−/−^* cells showed no caspase-1 activation in response to LFn-flagellin among the three bacterial ligands ([Fig. 1 A](#fig1){ref-type="fig"}). In contrast, *Naip5^−/−^* BMDMs exhibited normal caspase-1 activation upon stimulation by LFn-BsaK and LFn-EprI. Similarly, *Naip2^−/−^* and *Naip1^−/−^* BMDMs only resisted LFn-BsaK and LFn-EprI stimulation, respectively ([Fig. 1 A](#fig1){ref-type="fig"}). When pyroptosis was examined in the aforementioned BMDMs, a perfect correlation between caspase-1 activation and pyroptosis was observed ([Fig. 1, C and D](#fig1){ref-type="fig"}). Collectively, these definitive genetic evidences support that NAIP1, NAIP2, and NAIP5 are specific intracellular receptors for bacterial T3SS needle protein, rod protein, and flagellin, respectively.

![***Naips* play nonredundant roles in specifically recognizing the corresponding bacterial ligands.** Flagellin (type b from *P. aeruginosa*), the T3SS rod protein (Bsak from *B. thailandensis*), and the needle protein (EprI from EHEC) were delivered into primary BMDMs derived from WT or the indicated knockout KO mice (C57BL/6 background) by using the LFn fusion strategy. LPS plus nigericin, an activator of the NLRP3 inflammasome, served as a control. (A and B) Macrophage supernatants or lysates were collected for anti--caspase-1 and/or anti-tubulin immunoblotting. (C and D) Lactate dehydrogenase (LDH) release--based cell death assays (mean values ± SD) are from three technical replicates. All data shown are representative of three independent experiments. Pro-CASP1, caspase-1 precursor; p10, mature caspase-1.](JEM_20160006_Fig1){#fig1}

*Naips* mediate lethal inflammasome activation in mice in a ligand-specific manner {#s04}
----------------------------------------------------------------------------------

Intraperitoneal injections of LFn-flagellin could kill the mice within several hours as a result of systemic hyperactivation of the NAIP5/NLRC4 inflammasome ([Fig. 2 A](#fig2){ref-type="fig"}; [@bib22]).The lethality was completely abrogated in *Nlrc4^−/−^* and *Naip5^−/−^* mice ([Fig. 2, B and C](#fig2){ref-type="fig"}). We further observed that injection of LFn-BsaK or LFn-EprI caused the same lethal effect, which was completely disrupted in the *Nlrc4^−/−^* mice ([Fig. 2, A and B](#fig2){ref-type="fig"}). The T3SS rod protein has the most potent biochemical activity in activating the NLRC4 inflammasome ([@bib30]; [@bib26]). Consistently, mice injected with LFn-BsaK died around 30 min, whereas the lethality in LFn-flagellin-- or LFn-EprI--injected mice took several hours to develop ([Fig. 2 A](#fig2){ref-type="fig"}). Notably, *Naip5^−/−^* gave no protection from LFn-BsaK-- and LFn-EprI--induced lethality ([Fig. 2 C](#fig2){ref-type="fig"}), but the *Naip1^−/−^* and *Naip2^−/−^* mice showed complete resistance to LFn-EprI and LFn-BsaK injection, respectively ([Fig. 2, D and E](#fig2){ref-type="fig"}). In contrast, both *Naip1^−/−^* and *Naip2^−/−^* mice remained sensitive to the other two bacterial ligands (flagellin and Bsak for *Naip1^−/−^* and flagellin and EprI for *Naip2^−/−^*). Similar results were obtained with other T3SS rod and needle proteins, such as PrgJ from *S.* Typhimurium and MxiH from *S. flexneri*, respectively (not depicted). These data agree well with the specific recognition of the T3SS rod and needle protein by NAIP2/1 observed in the cell culture system. The results also highlight the nonredundant function of NAIPs in mediating lethal NLRC4 inflammasome activation in mice by the bacterial ligands.

![***Naips* mediate lethal inflammasome activation in the ligand-specific manner.** (A--E) Lethal doses of LFn-tagged T3SS rod protein (Bsak from *B. thailandensis*), needle protein (EprI from EHEC), and *P. aeruginosa* flagellin (Fla) were peritoneally injected into WT, *Naip1^−/−^*, *Naip2^−/−^*, *Naip5^−/−^*, or *Nlrc4^−/−^* mice (C57BL/6 background) together with equal amounts of the protective antigen protein. The mouse survival curve analysis (six mice for each group) was performed in Prism 5. \*, P ≤ 0.05. All data shown are representative of three independent experiments.](JEM_20160006_Fig2){#fig2}

The role of *Naips* in macrophage responses to various bacterial infections {#s05}
---------------------------------------------------------------------------

Having defined the ligand specificity of different NAIPs using the LFn-mediated delivery system, we then examined the role of each *Naip* in sensing various bacterial infections. Monomeric flagellin can be secreted out of the bacteria through the T3SS or type 4 secretion system. The T3SS rod and needle proteins, essential for assembly of a functional T3SS, can also be secreted into host cytosol during infection. Mutation of genes encoding flagellin and T3SS rod/needle proteins are expected to affect one another and cause other unintended interference on bacterial physiology ([@bib26]). However, the individual *Naip^−/−^* cells allowed for dissecting the contribution of a particular bacterial ligand to infection-induced inflammasome activation. Five different pathogenic bacteria, including *B. thailandensis*, *C. violaceum*, *Legionella pneumophila*, *S.* Typhimurium, and *S. flexneri*, which can all activate caspase-1 in an NLRC4-dependent manner ([@bib28]), were used to infect the *Naip^−/−^* BMDMs. Consistent with a previous study ([@bib11]), *Naip5^−/−^* abolished caspase-1 activation and pyroptosis in response to *L. pneumophila* infection ([Fig. 3, A and B](#fig3){ref-type="fig"}). Deletion of the flagellin-encoding gene *flaA* resulted in similar disruption of caspase-1 activation and pyroptosis in infected WT BMDMs. *L. pneumophila* harbors no T3SS and triggered the same level of inflammasome activation in *Naip2^−/−^* BMDMs as in WT cells ([Fig. 3, A and B](#fig3){ref-type="fig"}). Different from that in *L. pneumophila* infection, deletion of any single *Naip* caused little inhibition on *B. thailandensis*-- and *C. violaceum*--induced pyroptosis despite the markedly reduced death in *Nlrc4^−/−^* BMDMs ([Fig. 3 C](#fig3){ref-type="fig"}). Given that NAIPs are the only known sensors upstream of NLRC4, this suggests that multiple NAIPs play a redundant role in recognizing the two bacteria. However, though less likely, it is possible that NLRC4 may have a NAIP-independent function in activating caspase-1.

![**The role of *Naips* in macrophage responses to various bacterial infections.** (A--C) Primary BMDMs derived from WT, *Naip1^−/−^*, *Naip2^−/−^*, or *Naip5^−/−^* mice (C57BL/6 background) were infected with *L. pneumophila*, *B. thailandensis*, or *C. violaceum*. (D--I) The BMDM cells were also infected with an indicated *S.* Typhimurium or *S. flexneri* strain at an MOI of 10 for 10 (D) or 30 min (F and G) or a higher MOI of 20 for 2 h (E--G) or 30 min (H and I). Macrophage supernatants or lysates were subjected to anti--caspase-1 and/or anti-tubulin immunoblotting (A, D, E, and H). Lactate dehydrogenase (LDH) release--based cell death assays (mean values ± SD) are from three technical replicates (B, C, F, and I). CFUs of *S.* Typhimurium and *S. flexneri* strains recovered from infected WT macrophages are in G (*n* = 3; mean ± SD). Δ*flaA* denotes the flagellin-deficient strain of *L. pneumophila*. Δ*fliC*Δ*fljB* and Δ*fliC*Δ*fljB*Δ*prgJ* denote the flagellin-deficient and the flagellin/rod protein double-deficient *S.* Typhimurium strains, respectively. Δ*mxiH* is the needle protein--deficient *S. flexneri* strain. All data shown are representative of three independent experiments. Pro-CASP1, caspase-1 precursor; p10, mature caspase 1.](JEM_20160006_Fig3){#fig3}

*S.* Typhimurium and *S. flexneri* are two extensively studied models for enteric bacteria. The virulence factors in *S.* Typhimurium are tightly regulated during infection; its *Salmonella* pathogenicity island (SPI)--1 T3SS is activated upon contact with the host cell whereas the SPI-2 T3SS is not turned on until successful invasion into the cytosol ([@bib3]). We observed that at the early time point after *S.* Typhimurium infection (multiplicity of infection \[MOI\] = 10), *Naip5^−/−^* BMDMs, compared with WT BMDMs, showed drastically reduced caspase-1 activation and pyroptosis, which also occurred in *Nlrc4^−/−^* but not *Naip1^−/−^* and *Naip2^−/−^* cells ([Fig. 3, D and F](#fig3){ref-type="fig"}). Under the same condition, deletion of flagellin-encoding genes (Δ*fliC*Δ*fljB*) produced a similar effect in WT macrophages. Thus, NAIP5 recognition of flagellin dominates the early inflammasome response in *S.* Typhimurium--infected macrophages. When the infection was performed at a higher MOI of 20 for 120 min, evident caspase-1 activation and pyroptosis could still be detected in *S.* Typhimurium Δ*fliC*Δ*fljB*-infected BMDMs ([Fig. 3, E and F](#fig3){ref-type="fig"}). This activation was diminished by additional deletion of *prgJ* encoding the SPI-I T3SS rod protein. As PrgJ is essential for SPI-1 T3SS assembly and the SPI-1 is critical for *S.* Typhimurium invasion and infection, results of the *prgJ* mutant could not tell the bacterial signal that was directly recognized by the inflammasome. Importantly, *S.* Typhimurium Δ*fliC*Δ*fljB*-induced caspase-1 activation and pyroptosis were largely abolished in *Naip2^−/−^* cells but remained intact in *Naip1^−/−^* and *Naip5^−/−^* cells ([Fig. 3, E and F](#fig3){ref-type="fig"}). The absence of flagellin and PrgJ did not affect *S.* Typhimurium infection and intracellular growth within the time period of infection ([Fig. 3 G](#fig3){ref-type="fig"}), suggesting that the decreased pyroptosis observed in mutant bacteria is not a result of differences in the amount of intracellular bacteria. These data suggest that the SPI-I T3SS rod protein PrgJ but not the needle protein PrgI is a major target of the NAIP/NLRC4 inflammasome at the late stage of *S.* Typhimurium infection. This is likely because NAIP1 is expressed poorly in BMDMs ([@bib26]).

*S. flexneri* is nonflagellar and contains one T3SS important for pathogenesis. siRNA knockdown experiments have shown that recognition of the T3SS needle protein MxiH by NAIP1 and human NAIP is an important defense response upon *S. flexneri* infection of mouse BM dendritic cells and human THP1 cells, respectively ([@bib26]). In mouse BMDMs, deletion of either *mxiH* or *mxiI* (encoding the T3SS rod protein) from *S. flexneri* both disrupted caspase-1 activation and pyroptosis ([Fig. 3, H and I](#fig3){ref-type="fig"}; [@bib20]). However, only *Naip2^−/−^* BMDMs and not *Naip1^−/−^* and *Naip5^−/−^* cells exhibited defective inflammasome activation in response to WT *S. flexneri* infection ([Fig. 3, H and I](#fig3){ref-type="fig"}). The extent of inhibition by *Naip2^−/−^* was comparable with that by *Nlrc4^−/−^*. Similar to that in *S.* Typhimurium, Δ*mxiH* did not affect *S. flexneri* intracellular growth ([Fig. 3 G](#fig3){ref-type="fig"}). Thus, cytosolic *S. flexneri* is mainly detected by NAIP2 in mouse BMDMs. Collectively, these results suggest that the role of a particular NAIP in cytosolic innate immunity is highly dependent on the bacterial species and the type of cells assayed as well as the infection condition.

The role of *Naips* in host defenses against systemic infection by engineered *S.* Typhimurium in mice {#s06}
------------------------------------------------------------------------------------------------------

*S.* Typhimurium is widely used for examining NLRC4-mediated inflammasome defense against bacterial infection. Mice succumb to peritoneal *S.* Typhimurium infection within a week because of the high virulence of the genus. Consistent with a previous study ([@bib14]), ectopic expression of flagellin or PrgJ under the SPI-II promoter in the bacteria protected the mice from *S.* Typhimurium--induced lethality ([Fig. 4 A](#fig4){ref-type="fig"}). This effect was diminished in *Nlrc4^−/−^* mice ([Fig. 4 B](#fig4){ref-type="fig"}), confirming the critical role of the NLRC4-mediated inflammasome responses in this process. *Naip2^−/−^* could also reverse the protection induced by enforced expression of PrgJ, but not that by flagellin ([Fig. 4 C](#fig4){ref-type="fig"}). Similarly, *Naip5^−/−^* mice remained resistant to PrgJ-expressing *S.* Typhimurium but succumbed to infection by the flagellin-expressing strain ([Fig. 4 D](#fig4){ref-type="fig"}). We also performed the same assay with *S.* Typhimurium expressing a T3SS needle protein such as PrgI, EprI, MxiH, or BsaL (from *B. thailandensis*), but in all cases, we observed no protection from infection-induced lethality ([Fig. 4 E](#fig4){ref-type="fig"}). This is consistent with the needle protein being generally less active than the rod protein and flagellin in activating the inflammasome ([@bib26]), likely because of the poor expression of NAIP1 in mice.

![**The role of *Naips* in mouse defenses against systemic infection by engineered *S.* Typhimurium.** (A--E and H) WT, *Naip2^−/−^*, *Naip5^−/−^*, or *Nlrc4^−/−^* mice (C57BL/6 background) were subjected to peritoneal infection with engineered *S.* Typhimurium strains. The numbers of mice used were five (A, C, and E), six (D), and seven (B). Sal-WT denotes WT *S.* Typhimurium harboring an empty vector (ampicillin resistant); Sal-PrgJ, Sal-FliC, and Sal-PrgI/EprI/BsaL/MxiH denote *S.* Typhimurium--expressing PrgJ, FliC, or indicated T3SS needle proteins, respectively, under the promoter of an SPI-II T3SS effector gene, *sseJ*. The mouse survival curve analysis was performed in Prism 5. \*, P ≤ 0.05. Representative photos of the spleens of the infected mice from A and C are in H. (F and G) Mice were infected similarly as those in A--D except that a WT *S.* Typhimurium strain harboring a kanamycin-resistant gene was included as an internal reference. The CI value of *S.* Typhimurium replication in the spleen and liver of mice (mean values ± SD) was determined 4--5 d after the infection. \*, P \< 0.05 (Student's *t* test). All data shown are representative of three independent experiments.](JEM_20160006_Fig4){#fig4}

We further investigated whether the protection observed with the engineered *S.* Typhimurium results from inhibition of bacterial replication. For this, we measured the competitive index (CI) in infected mice, similarly as previously performed in *Nlrc4^−/−^* mice ([@bib14]). When the liver and the spleen from the infected mice were examined, bacterial loads in these organs from infection with the flagellin or PrgJ-expressing *S.* Typhimurium were found to be lower than that of the coinfected reference WT strain by more than three orders of magnitude ([Fig. 4, F and G](#fig4){ref-type="fig"}). Comparable levels of WT bacteria bearing different antibiotic resistance were recovered from the mice, suggesting that different antibiotic markers used in the engineered strain and the reference strain were not the cause for the observed lower bacterial loads. Remarkably, the lowered bacterial loads were specifically blocked in *Naip5^−/−^* and *Naip2^−/−^* mice for flagellin- and PrgJ-expressing *S.* Typhimurium, respectively ([Fig. 4, F and G](#fig4){ref-type="fig"}). Moreover, we consistently observed markedly enlarged spleens and abnormal livers in mice that failed to clear the bacteria ([Fig. 4 H](#fig4){ref-type="fig"} and not depicted). This is consistent with the notion that a higher load of bacteria could cause pathological effects and disrupt normal tissue homeostasis. These data suggest that *Naips* play critical roles in clearing bacterial infection by recognizing the cognate bacterial ligand and activating inflammasome-mediated defenses.

In summary, using *Naip1^−/−^*, *Naip2^−/−^*, and *Naip5^−/−^* mice, we provided definitive genetic evidences that highlight the in vivo function of the NAIPs in innate defense against cytosolic bacteria as well as in mediating lethal inflammasome activation by flagellin and the T3SS apparatus. Our *Naip^−/−^* mice also allowed for demonstrating the high specificity of NAIP1, 2 and, 5 in recognizing bacterial T3SS needle protein, rod protein, and flagellin, respectively. Recent studies have depicted a structural model for how ligand binding to a single NAIP receptor relays the activation signal to the NLRC4 adaptor and triggers the assembly of the NAIP--NLRC4 complex ([@bib8]; [@bib27]). Because of the limited resolution of the cryo-electron microscopy model, further studies, ideally crystal structure of the ligand--NAIP complex, are needed to develop full mechanistic understanding of the ligand specificity of NAIP receptors. This is particularly interesting given that NAIPs do not use the presumed leucine-rich repeat domain to bind to the ligands ([@bib21]).

The *Naip^−/−^* mice generated in our study are also useful for dissecting the differential contributions of different bacterial signals to host defenses against a particular bacterial infection. It is worth mentioning that mice also express NAIP6. NAIP6 shares the highest sequence identity of 94.7% with NAIP5, and the two NAIPs are biochemically indistinguishable in binding to certain flagellin and activating NLRC4 in cell culture assays ([@bib30]). NAIP6 has a much lower expression than NAIP5 in BMDM cells. Our genetic experiments, as well as a previous study ([@bib11]), appear to suggest that NAIP5 accounts for all observed inflammasome responses induced by the flagellin assayed. Thus, NAIP6 may have a specific cell type--dependent function in response to certain flagellin variants. Generating *Naip6^−/−^* mice and profiling a larger panel of flagellins from different bacteria shall help to address NAIP6 function in inflammasome-mediated antibacterial defenses.

MATERIALS AND METHODS {#s07}
=====================

 {#s08}

### KO mice {#s09}

C57BL/6 WT mice were purchased from Vital River Laboratory Animal Technology Co. *Nlrc4^−/−^* mice on the 129s background were provided by V. Dixit (Genentech) and backcrossed for \>10 generations to the C57BL/6 background in our facility. All animal experiments were conducted according to the Ministry of Health national guidelines for housing and care of laboratory animals and performed in accordance with institutional regulations after review and approval by the Institutional Animal Care and Use Committee at National Institute of Biological Sciences, Beijing.

*Naip5^−/−^* mice were generated through conventional ES cell--based targeting. The targeting vector was constructed by using recombineering technology. In brief, a *Naip5* genomic fragment containing both homologous arms and the targeted region was retrieved from a bacterial artificial chromosome plasmid (BAC RP23-434I9; obtained from the BACPAC Resources Center, Children's Hospital Oakland, Oakland, CA) and cloned into a targeting vector by homologous recombination. A neomycin-coding cassette was then inserted into the targeting vector, also through homologous recombination, to replace the largest exon 9 (illustrated in Fig. S1 A). The targeting vector was linearized and electroporated into the C57BL/6-derived Bruce4 ES cell. Neomycin-resistant clones were picked and validated by PCR and DNA sequencing. Targeted ES cells were injected into recipient blastocysts, and germline transmission was screened by PCR and DNA sequencing. *Naip1^−/−^* and *Naip2^−/−^* mice were generated by TALEN-mediated genome editing in fertilized eggs (C57BL/6 background). The TALEN constructs were assembled according to a previously published protocol ([@bib23]; the *Naip1* TALEN construct was provided by J. Xi from Peking University, Beijing, China). The targeting sequences were 5′-TAAGAAATCTTCAGAGG-3′ (left) and 5′-TCCCTCATAGCCTTGGAT-3′ (right) for *Naip1* and 5′-TAGAGACCAGGACCACAGT-3′ (left) and 5′-TAGGTCCCACTGGATG-3′ (right) for *Naip2*. Detailed protocols for generating the TALEN KO mice were the same as previously described for the *Mefv^−/−^* mice ([@bib25]). All biallelic KO mice were obtained by intercrossing the offspring of the founders. The genotyping primers used were 5′-CAACACCCTCCCCAACAAAC-3′ (*Naip1*-F), 5′-CCCATGCTGTCTGCAGATGTT-3′ (*Naip1*-R), 5′-CTAGGAGGTTTGAATGCATTTCAA-3′ (*Naip2*-F), 5′-GGAGAAGACCTCAGGGATCGTC-3′ (*Naip2*-R), 5′-ACCCACAATCTCAGAACCAGAAAACC-3′ (*Naip5*-F), and 5′-TGTTGGTAGAGAGTCATTGTTGGCCT-3′ (*Naip5*-R).

### Bacterial strains and infections {#s10}

Primary BMDM cells used for bacterial infection were prepared from WT and the indicated KO mice (C57BL/6 background) according to a previously described protocol ([@bib30]). All bacterial strains used in this study have also been described in our previous publications ([@bib30]; [@bib26]). *S.* Typhimurium and *S. flexneri* strains were cultured in the 2xYT medium, and *L. pneumophila* were cultured on buffered charcoal yeast extract agar supplemented with 0.1 mg/ml^−1^ thymidine (BCYET). For infection, *L. pneumophila* were scraped from the agar plate and diluted in sterile water. Overnight cultures of *S.* Typhimurium ATCC 14028s (WT or indicated mutant strains; provided by E. Miao, University of North Carolina at Chapel Hill, Chapel Hill, NC), *S. flexneri* 2457T, or other indicated bacteria were diluted by 1:100 and grown for another 3 h to induce T3SS expression. The infection was performed at the indicated MOI, facilitated by centrifugation of 1,000 *g* for 10 min at 30°C and stopped at indicated time points. Cells were washed and cultured in media containing 100 µg/ml^−1^ gentamicin to kill the extracellular bacteria. The CFU numbers measuring the amount of intracellular bacteria were determined by dilution plating. For systemic infection in mice, overnight culture of *S.* Typhimurium SL1344 (provided by B. Finlay, University of British Columbia, Vancouver, BC, Canada) was diluted in PBS, and a total of 1,000 bacteria were used for intraperitoneal infection. Survival of the mice was monitored every 12 h after the infection.

### CI assay of bacterial replication in mice {#s11}

The CI assay of *S.* Typhimurium replication was performed according to a previous publication ([@bib14]). All mice were on the C57BL/6 background WT mice were from Vital River Laboratory Animal Technology Co. In brief, an ampicillin-resistant vector (pWSK29) expressing PrgJ or flagellin under the promoter of the SPI-II effector SseJ was transformed into *S.* Typhimurium. WT *S.* Typhimurium transformed with an empty vector harboring a kanamycin resistance gene was used as the internal reference. An equal number of experimental bacteria and reference bacteria (500 bacteria for each strain) were intraperitoneally injected into the mice. The spleens and livers of mice from the control group and experimental group, sacrificed at the same time point, were homogenized, and the CFUs were determined. CI results were presented as log (experimental/reference CFUs).

### LFn fusion protein purification and injection into mice {#s12}

LFn-tagged recombinant flagellin (type b from *P. aeruginosa*), T3SS rod proteins (BsaK from *B. thailandensis* and PrgJ from *S.* Typhimurium), T3SS needle proteins (EprI from EHEC, PrgI from *S.* Typhimurium, BsaL from *B. thailandensis*, and MxiH from *S. flexneri*), and protective antigen proteins were expressed and purified as described in our previous publications ([@bib30]; [@bib26]). For injection into mice, proteins were diluted in 200 µl of PBS; the dosages used were 2 µg for the rod protein and 5 µg for flagellin and the needle protein per gram of mice. Cytosolic delivery was achieved by co-injecting equal amounts of the protective antigen. Injected mice were observed every few hours, and the survival rate was calculated. All mice were on the C57BL/6 background, and the WT mice were purchased from Vital River Laboratory Animal Technology Co.

### Statistical analyses {#s13}

Mouse survival data after bacterial infection or protein injection were analyzed in Prism 5 (GraphPad Software), in which the log-rank (Mantel-Cox) test was used for statistical analyses of the survival curve (p-values ≤0.05 were considered significant). The two-tailed unpaired Student's *t* test was used for statistical analyses of the CI data, and p-values \<0.05 were considered significant.

### Online supplemental material {#s14}

Fig. S1 shows the generation of *Naip1*, *Naip2*, and *Naip5* KO mice. The strategy for removing the exon 9 of mouse *Naip5* by homologous recombination is shown in A, and genotyping results of the *Naip5^−/−^* mice are in B. C and D show the sequence mutations of *Naip1^−/−^* and *Naip2^−/−^* mice generated by TALEN-mediated genome editing. Online supplemental materials are available at <http://www.jem.org/cgi/content/full/jem.20160006/DC1>.
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